Acurx Pharmaceuticals, Inc. (ACXP)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-01-06Scodari Joseph CdirectorP24,6311.02$25,124
2025-01-06Sailer CarldirectorP24,6311.02$25,124
2025-01-06LUCI DAVID PdirectorP49,2611.02$50,246
2025-01-06Donohue James J.directorP9,8521.02$10,049
2025-01-06DELUCCIA ROBERT JdirectorP49,2611.02$50,246
2025-01-06DEAN JACK HdirectorP9,8521.02$10,049

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings